Tag Archives: tyrosine kinase inhibitor

Big News in Cancer Treatment for Dogs!

July 21, 2009OncologyACVD, ACVIM, andrea flory, animal hospital, animal medical center, animals, ann hohenhaus, cancer dog, canine cancer, canine mast cell tumor, chemotherapy, dog, dogs, fatty tumor, FDA, gleevec, health, john farrelly, mast cell tumor, new york vet, nicole leibman, Oncology, palladia, pet, pet emergency, pet health, pet healthcare, pet insurance, pet owner, pets, pfizer animal health, skin tumor, tyrosine kinase inhibitor, Uncategorized, vet, veterinarian, veterinary care, veterinary internal medicine, veterinary oncologygb_dev

Just last month, veterinary oncology had a first and as a board certified veterinary oncologist, this news just made my day. Until now, all chemotherapy agents administered to dogs were human drugs adapted for use by veterinarians. In June, the Food and Drug Administration’s Center for Veterinary Medicine approved the use of Palladia® (toceranib phosphate)